Remnant pancreatic carcinoma: The current status

doi:10.5306/wjco.v16.i5.107039

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=0

May 24, 2025 (publication date) through May 19, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. May 24, 2025; 16(5): 107039
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.107039

Remnant pancreatic carcinoma: The current status

Ankit Shukla, Raja Kalayarasan, Pothugunta Sai Krishna, Biju Pottakkat

Ankit Shukla, Department of Surgery, Dr Rajendra Prasad Government Medical College, Tanda 176001, India

Raja Kalayarasan, Pothugunta Sai Krishna, Biju Pottakkat, Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry 605006, India

Author contributions: Shukla A and Kalayarasan R contributed to the conceptualization, writing, and editing of this manuscript; Sai Krishna P and Pottakkat B contributed to the article screening and writing; Shukla A, Kalayarasan R, and Sai Krishna P contributed to the literature search; All authors read and agreed to the published version of the manuscript.

Conflict-of-interest statement: The authors declare that they have no conflicts of interest.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Ankit Shukla, MD, Assistant Professor, Department of Surgery, Dr Rajendra Prasad Government Medical College, Kangra Chamunda bypass NH-20, Tanda 176001, India. nkitshukla@gmail.com

Received: March 13, 2025
Revised: March 31, 2025
Accepted: April 11, 2025
Published online: May 24, 2025
Processing time: 66 Days and 18.3 Hours

Core Tip

Core Tip: The incidence of remnant pancreatic cancer is increasing as advances in diagnostic modalities and better multidisciplinary management have contributed to improved survival in patients with pancreatic cancer. Recognition of various genetic factors may help in the early detection of remnant pancreatic carcinoma and provide better management. Recent trends show a shift towards surgical management of remnant pancreatic cancer. However, managing remnant pancreatic carcinoma needs further detailed introspection and research to optimize outcomes.